Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and lenvatinib

fluorodeoxyglucose f18 has been researched along with lenvatinib in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (25.00)24.3611
2020's6 (75.00)2.80

Authors

AuthorsStudies
Bible, KC; Jasim, S; Nathan, MA1
Ariga, S; Dosaka-Akita, H; Gouda, T; Hirata, K; Homma, A; Homma, R; Iijima, H; Kinoshita, I; Magota, K; Ohhara, Y; Shiga, T; Shimizu, Y; Taguchi, J; Takeuchi, S; Tamaki, N; Tsuji, Y1
Aoyama, M; Bando, Y; Inoue, S; Kawakita, N; Kondo, K; Otani, T; Takizawa, H; Tangoku, A; Tsuboi, M; Uehara, H1
Akuta, N; Arase, Y; Fujiyama, S; Hashimoto, M; Hosaka, T; Ikeda, K; Iritani, S; Kajiwara, A; Kawamura, Y; Kobayashi, M; Kobayashi, Y; Kumada, H; Muraishi, N; Okubo, S; Saitoh, S; Sezaki, H; Shindoh, J; Suzuki, F; Suzuki, Y; Yamashige, D1
Gao, J; Gong, R; Gong, Y; Li, Z; Ma, Y; Yang, J; Zhu, J1
Boni, G; Elisei, R; Giani, C; Guidoccio, F; Minaldi, E; Puccini, G; Puleo, L; Tardelli, E; Valerio, L; Volterrani, D1
Akuta, N; Arase, Y; Fujiyama, S; Hashimoto, M; Hosaka, T; Ikeda, K; Iritani, S; Kawamura, Y; Kobayashi, M; Kobayashi, Y; Kumada, H; Muraishi, N; Okubo, S; Saitoh, S; Sezaki, H; Shindoh, J; Suzuki, F; Suzuki, Y1
Liu, J; Lu, S; Luan, X; Ma, G; Wang, G; Wang, R; Wang, Z; Xu, B; Xu, X; Zhang, J; Zhang, W1

Other Studies

8 other study(ies) available for fluorodeoxyglucose f18 and lenvatinib

ArticleYear
"Pseudo-progression" in advanced thyroid cancer in response to kinase inhibitor therapy.
    Endocrine, 2017, Volume: 57, Issue:1

    Topics: Antineoplastic Agents; Carcinoma, Papillary; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Phenylurea Compounds; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinolines; Thyroid Neoplasms; Thyroidectomy; Thyrotropin

2017
Early prediction of lenvatinib treatment efficacy by using
    BMJ open, 2018, 08-30, Volume: 8, Issue:8

    Topics: Adult; Antineoplastic Agents; Clinical Protocols; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Phenylurea Compounds; Positron-Emission Tomography; Quinolines; Thyroid Gland; Thyroid Neoplasms; Treatment Failure; Treatment Outcome

2018
Non‑invasive monitoring of paclitaxel and lenvatinib efficacy against anaplastic thyroid cancer in orthotopic SCID mouse models using small‑animal FDG‑PET/CT.
    Oncology reports, 2020, Volume: 44, Issue:4

    Topics: Animals; Cell Line, Tumor; Fluorodeoxyglucose F18; Humans; Mice; Paclitaxel; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Protein Kinase Inhibitors; Quinolines; Thyroid Carcinoma, Anaplastic; Tumor Burden; Xenograft Model Antitumor Assays

2020
Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment.
    Oncology, 2021, Volume: 99, Issue:3

    Topics: Administration, Oral; Aged; Aged, 80 and over; alpha-Fetoproteins; Antineoplastic Agents; Carcinoma, Hepatocellular; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Middle Aged; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Quinolines; Retrospective Studies; Treatment Outcome

2021
Case Report: A New Entity: Multiple Differentiated Variant of Papillary Thyroid Carcinoma With Advanced Clinical Behavior.
    Frontiers in endocrinology, 2021, Volume: 12

    Topics: Biopsy, Fine-Needle; Carcinoma, Papillary; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Liver Neoplasms; Lymphatic Metastasis; Male; Medical Oncology; Middle Aged; Neck Dissection; Pancreatic Neoplasms; Phenylurea Compounds; Positron-Emission Tomography; Quinolines; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Whole Body Imaging

2021
[18F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient Survival.
    The Journal of clinical endocrinology and metabolism, 2021, 07-13, Volume: 106, Issue:8

    Topics: Adenocarcinoma, Follicular; Adult; Aged; Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Quinolines; Survival Rate; Thyroid Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Whole Body Imaging

2021
Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Overall Prognosis Following Lenvatinib Treatment.
    Oncology, 2021, Volume: 99, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Male; Middle Aged; Phenylurea Compounds; Positron Emission Tomography Computed Tomography; Prognosis; Quinolines; Radiopharmaceuticals; Survival Rate; Treatment Outcome

2021
The role of
    Frontiers in immunology, 2023, Volume: 14

    Topics: Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Programmed Cell Death 1 Receptor

2023